Open official notice

Two lots of omnitrope injectable human growth hormone recalled

Official notice

8 Jul 2026

Last checked

13 Nov 2026

RecallScope risk estimate:HighHealth Canada

An official Health Canada notice concerns Two lots of omnitrope injectable human growth hormone recalled. Sandoz Canada Inc. Is recalling two lots of Omnitrope 5 mg/1.5 mL somatropin after receiving complaints of cracked and leaking glass cartridges. Cracked and leaking cartridges may lead to contamination and infection, and to lower doses than intended. Omnitrope is a prescription drug that contains somatropin, a human growth hormone that is administered by subcutaneous injection (under the skin). Omnitrope is used to treat both adults and children with growth hormone deficiency, and to treat children who have not reached or maintained normal growth by the age of two years, or who have Turner syndrome. Injecting contaminated Omnitrope subcutaneously may lead to local or systemic infection (i.e., near the injection site or throughout the body). Glass particles may cause local tissue irritation and may lead to local tissue infections or abscesses (pus-filled lumps). Lower doses of Omnitrope over a long period of time (weeks) may also reduce its effectiveness. Health Canada is monitoring the company's recall and investigation, including its implementation of corrective and preventive actions to prevent this issue from reoccurring, and will inform the public if new risks are identified. Published 2026-07-08.

What to do now

If you have a recalled product, do not use it. Contact your pharmacy immediately for a replacement. Return the recalled product to your pharmacy for proper disposal. If you or your child have used this product and experience any unusual symptoms (e.g. Persistent redness, swelling and/or pain at the injection site, fever) or have any other health concerns, consult a healthcare professional. Contact Sandoz Canada Inc. By calling toll-free at 1-800-343-8839 if you have questions about this recall. Report any health product-related side effects or complaints to Health Canada.

Recall number

82295

Official notice

2026-07-08

The hazard

Sandoz Canada Inc. Is recalling two lots of Omnitrope 5 mg/1.5 mL somatropin after receiving complaints of cracked and leaking glass cartridges. Cracked and leaking cartridges may lead to contamination and infection, and to lower doses than intended. Omnitrope is a prescription drug that contains somatropin, a human growth hormone that is administered by subcutaneous injection (under the skin). Omnitrope is used to treat both adults and children with growth hormone deficiency, and to treat children who have not reached or maintained normal growth by the age of two years, or who have Turner syndrome. Injecting contaminated Omnitrope subcutaneously may lead to local or systemic infection (i.e., near the injection site or throughout the body). Glass particles may cause local tissue irritation and may lead to local tissue infections or abscesses (pus-filled lumps). Lower doses of Omnitrope over a long period of time (weeks) may also reduce its effectiveness. Health Canada is monitoring the company's recall and investigation, including its implementation of corrective and preventive actions to prevent this issue from reoccurring, and will inform the public if new risks are identified.

How to check if you’re affected

Compare the product name and identifiers below with the item you own. Check the official notice for the affected products and next steps.

Lots

PR7350, PR7351

Other

RA RA-82295

Recall Numbers

82295

Checked manually this time?

Follow brands and keywords in the app to receive alerts for matching official notices.

Turn on recall alerts

Affected products

Product 1

Product - Omnitrope (5 mg/1.5 mL somatropin)- Box of 1 cartridge, Lot - PR7350

Product 2

Product - Omnitrope (5 mg/1.5 mL somatropin)- Box of 5 cartridges, Lot - PR7351

Hazard

Sandoz Canada Inc. Is recalling two lots of Omnitrope 5 mg/1.5 mL somatropin after receiving complaints of cracked and leaking glass cartridges. Cracked and leaking cartridges may lead to contamination and infection, and to lower doses than intended. Omnitrope is a prescription drug that contains somatropin, a human growth hormone that is administered by subcutaneous injection (under the skin). Omnitrope is used to treat both adults and children with growth hormone deficiency, and to treat children who have not reached or maintained normal growth by the age of two years, or who have Turner syndrome. Injecting contaminated Omnitrope subcutaneously may lead to local or systemic infection (i.e., near the injection site or throughout the body). Glass particles may cause local tissue irritation and may lead to local tissue infections or abscesses (pus-filled lumps). Lower doses of Omnitrope over a long period of time (weeks) may also reduce its effectiveness. Health Canada is monitoring the company's recall and investigation, including its implementation of corrective and preventive actions to prevent this issue from reoccurring, and will inform the public if new risks are identified.

Where it was sold

Retailer information is not currently available in RecallScope. Check the official notice for distribution details.

Location 1

CA · Canada

Affected area 1

CA · Canada

Company & contacts

Manufacturer

your pharmacy immediately for a replacement

Phone

1-800-343-8839

Brand: Omnitrope. Contact: your pharmacy immediately for a replacement. Phone 1-800-343-8839.

Source & status

Tier

beta

Category

Health

Official classification

Type I

Recall details

Recall number

82295

Source tier

beta

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Weekly recall digest

Get next week’s recalls before you need them.

One email every Monday with official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest arrives once a week. For matching recall alerts after notices are processed, get the app.

This recall was published 8 Jul 2026. The next one won’t wait for you to search.

RecallScope checks listed publishers for the brands and VINs you follow, and can alert you when a matching notice is processed.

apple-buttongoogle-button